Novus Biologicals products are now on bio-techne.com

VEGF

Unlocking the Potential of Biosimilars in Immuno-Oncology

Understanding ‘Y’ in Breast Cancer: Crucial Role of DNA/RNA-binding Protein YB-1 in the Development, Pre-Invasive, and Metastatic Phases

Detecting HIF alpha and beyond: Best controls for hypoxia Western blot analysis

Neurovascular signaling for repair enhances brain metastasis

mTOR Signaling and the Tumor Microenvironment

Chemotherapy-induced metastasis: An unexpected foe?

Getting Physical: Link between Lipid Metabolism and Hypoxia Target Genes

Autophagy Mechanisms

By Jamshed Arslan Pharm.D.

Marked for Deletion: Parkin Ubiquitinylates HIF-1α to Stop Cancer

Parkin Ubiquitinylates HIF-1 alpha

By Jamshed Arslan Pharm.D.

Potential therapies for human ovarian cancer surrounding the PI3K/AKT/mTOR pathway

Mammalian target of Rapamycin (mTOR) is a serine/threonine kinase that regulates cell growth, proliferation, motility and survival.

The role of HIF-2 alpha in the progression and therapy of clear cell renal cell carcinoma

HIF-2 alpha, also known as hypoxia-inducible factor 2, endothelial PAS domain protein-1, and member of PAS superfamily 2 is part of the HIF family of proteins.  The HIF family is composed of HIF-1, HIF-2 and HIF-3, where HIF-2 is a dimeric protein that consists of an alpha and beta subunit.HIF-2 alphais activated in the presence of oxygen deprivation, or hypoxia, via prolyl hydroxylase-domain enzymes (PHD

Pages